Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

875 public trials 117 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Fort Smith, Arkansas, United States
  • Novartis Investigative Site Fountain Valley, California, United States
View all 105 locations
View Trial Details
Recruiting

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

NCT06808477

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • First OC Dermatology Irvine, California, United States
  • OptiSkin Medical New York, United States
  • Equity Medical, LLC The Bronx, New York, United States
  • Fremantle Dermatology Fremantle, Western Australia, Australia
View all 14 locations
View Trial Details
Recruiting

A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment

NCT06192563

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number: 002 Bologna, Italy
  • Investigational Site Number: 006 Brescia, Italy
  • Investigational Site Number: 004 Florence, Italy
  • Investigational Site Number: 001 Milan, Italy
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT07037901

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Inmagene Site 1 Lancaster, California, United States
  • Inmagene Site 23 Los Angeles, California, United States
  • Inmagene Site 19 Ocala, Florida, United States
  • Inmagene Site 4 Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

NCT06461897

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Integrative Skin Science and Research /ID# 265108 Sacramento, California, United States
  • Clearlyderm Dermatology - West Boca /ID# 266323 Boca Raton, Florida, United States
  • Neoclinical Research - Hialeah /ID# 269694 Hialeah, Florida, United States
  • Cleaver Medical Group Dermatology /ID# 265099 Dawsonville, Georgia, United States
View all 150 locations
View Trial Details
Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

NCT07290803

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Cahaba Dermatology & Skin Health Center- Site Number : 8400006 Birmingham, Alabama, United States
  • River Region Dermatology and Laser- Site Number : 8400041 Montgomery, Alabama, United States
  • San Tan Allergy & Asthma- Site Number : 8400031 Gilbert, Arizona, United States
  • Kern Research, Inc.- Site Number : 8400047 Bakersfield, California, United States
View all 79 locations
View Trial Details

Related conditions